1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Improving seizure control in tuberous sclerosis – Epilepsy Research UK

August 14, 2013Immunosuppressive Drugsadmin

Epilepsy Research UK

Improving seizure control in tuberous sclerosis
Epilepsy Research UK
A drug known as everolimus, which was originally developed to prevent rejection following organ transplantation, has shown effectiveness in the treatment of many aspects of TSC. Its function is to block (inhibit) a protein called mTOR, which plays an ...

Post navigation

← US FDA grants fast track status to Galectin's GR-MD-02 for fatty liver disease … – pharmabiz.com RESEARCH AND MARKETS: Cancer Monoclonal Antibodies Market Forecast to … – 4-traders (press release) →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos